Search Results - "Valsami, S."
-
1
Effect of mirasol pathogen reduction technology system on immunomodulatory molecules of apheresis platelets
Published in Transfusion and apheresis science (01-02-2023)“…Pathogen inactivation for platelets by riboflavin system (MIRASOL) efficiently reduces transfusion related pathogen transmission. However little is known about…”
Get full text
Journal Article -
2
A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes
Published in BMC neurology (29-10-2018)“…Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to…”
Get full text
Journal Article -
3
Seroprevalence of hepatitis E virus in blood donors in Greece
Published in Vox sanguinis (01-05-2014)Get full text
Journal Article -
4
-
5
Alloimmunisation during pregnancy in Greece: need for nationwide HDFN prevention programme
Published in Transfusion medicine (Oxford, England) (01-08-2013)“…SUMMARY Aim/Objectives To access the incidence and specificity of maternal red blood cells alloimmunisation and its relevant clinical impact in Greece…”
Get full text
Journal Article -
6
A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4
Published in Haematologica (Roma) (01-10-2007)“…From the Second Department of Internal Medicine, Attikon University General Hospital, Haidari, Athens, Greece (SV, VP, FK, EP, JD, SP, NX, TE); Pathology…”
Get full text
Journal Article -
7
Monoclonal gammopathies in B-cell non-Hodgkin’s lymphomas
Published in Leukemia research (01-06-2003)“…The association of monoclonal gammopathy (MG) with B-cell non-Hodgkin’s lymphomas (NHL) is a well known phenomenon. The aim of the present work was to study…”
Get full text
Journal Article -
8
Immunohistochemical Analysis of the Expression of the B- Cell Markers BCL-6, MUM1/IRF4, CD79A and Transcription Factors BOB.1 and OCT.2 in Classical Hodgkin Lymphoma
Published in Blood (16-11-2005)“…INTRODUCTION: Classical hodgkin's lymphoma can be considered in most cases as a B-cell lymphoma by the presence of potentially functional immunoglobulin gene…”
Get full text
Journal Article -
9
Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma: A pilot study
Published in Leukemia research (01-12-2003)“…Rituximab is a chimeric monoclonal antibody that binds specifically to the CD20 antigen expressed in most B cell lymphomas. As single agent or in combination…”
Get full text
Journal Article -
10
Primary mediastinal large B-cell lymphoma: clinical study of a distinct clinical entity and treatment outcome in 20 patients: review of the literature
Published in American journal of clinical oncology (01-06-2004)“…Primary mediastinal B-cell lymphoma (PMBCL) is a discrete subset of large B-cell lymphoma with unique clinicopathologic features. The question of optimal…”
Get full text
Journal Article